Developed new software tools to allow for increased efficiency and functionality in handling large and
complex claims data sets using Perl, R, Tableau, Google Motion Charts, Circos, SQL, and 3M PPE.
Designed and executed research projects using physician, inpatient, outpatient, and pharmacy claims along
with enrollment data to aid in the development of health care policy, acting as an internal consultant to OHCA staff in determining the appropriate analysis for specific clinical questions.
Evaluated the analytical validity, clinical validity, and clinical utility of emerging genetic technologies,
including FDA-approved products and proprietary, lab-developed tests.
Developed evidence-based policies, guidelines, and reimbursement rates for coverage of genetic tests
and technologies for populations served by Oklahoma’s Medicaid agency.
Acted as a liaison between Oklahoma Medicaid and providers, working toward appropriate
utilization of genetic products and technologies.
Produced and delivered educational presentations on genetics to key internal and external
stakeholders, including the Medicaid Evidence-Based Decisions Project, the Oklahoma Health Care
Authority Board, the OK Hospital Association, and the University of OK College of Pharmacy.